The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Notification of Major Interest in Shares

25 Mar 2009 09:30

RNS Number : 4424P
ReGen Therapeutics PLC
25 March 2009
 



25th March 2009

REGEN THERAPEUTICS PLC 

("ReGen" or the "Company"; Ticker: (RGT))

TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

 

2. Reason for the notification:

An acquisition or disposal of voting rights 

 

3. Full name of person(s) subject to the notification obligation (iii):

Barclays PLC

 

4. Full name of shareholder(s) (if difference from 3):

Barclays Stockbrokers Ltd

5. Date of the transaction and date on which the threshold is crossed or reached (v):

20th March 2009

6. Date on which issued notified:

24th March 2009

7. Threshold(s) that is/are crossed or reached:

8% to 9%

 

8. Notified details 

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code GB00B28XMY25

Situation Previous to the triggering transaction (vi) -

Number of Shares 1,688,233

Number of Voting Rights (viii) 1,688,233

Resulting situation after the triggering transaction (viii) -

Number of Shares 1,878,233

Number of Voting Rights - Direct (x) N/A

Number of Voting Rights - Indirect (xi) 1,878,233

% of voting rights - Direct N/A

% of voting rights - Indirect 9.45

 

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument N/A

Expiration date (xiii) N/A

Exercise/Conversion Period/Date (xiv) N/A

Number of voting rights that may be acquired if the 

instrument is exercised/converted N/A

% of voting rights N/A

Total (A+B)

Number of voting rights 1,878,233

% of voting rights 9.45

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Barclays Stockbrokers Ltd

 

Proxy Voting:

 

10. Name of the proxy holder: N/A

 

11. Number of voting rights proxy holder will cease to hold: N/A

 

12. Date on which proxy holder will cease to hold voting rights: N/A

 

13. Additional information: N/A

 

14. Contact name: Geoff Smith

 

15. Contact telephone number: 0207 116 2913

For further information:

Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel: 020 7628 3396 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPUUQPWUPBUBA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.